Form 4: MaxLinear Director Sells Shares in Planned Transactions

MaxLinear Director Daniel A. Artusi sold a total of 29,802 shares of common stock over two days in pre-arranged transactions.

Summary

• Director Daniel A. Artusi sold 9,055 shares of MaxLinear common stock on October 29, 2025, at a price of $15.8693 per share.
• Artusi subsequently sold an additional 20,747 shares on October 30, 2025, at a weighted average price of $15.3928 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 pre-arranged trading plan.
• Following these sales, Daniel A. Artusi beneficially owns 12,141 shares of MaxLinear common stock directly.

Sentiment

Score: 5

Explanation: The sale of shares by a director is generally viewed neutrally to slightly negatively. However, the explicit mention of a Rule 10b5-1 plan mitigates the negative perception, as it indicates a pre-scheduled transaction rather than an immediate reaction to new information.

Negatives

• Director selling a significant number of shares, which could be perceived negatively by some investors, even if pre-planned.

Stakeholder Impact

• Shareholders may interpret the director's sale as a lack of confidence, though the 10b5-1 plan suggests it is for personal financial planning rather than market timing.

Key Dates

Recommendation

While a director's sale of shares might typically signal a negative outlook, the explicit disclosure that these transactions were conducted under a Rule 10b5-1 plan suggests they are part of a pre-scheduled personal financial strategy rather than a reaction to new, undisclosed negative information. Therefore, this filing alone does not provide sufficient new information to warrant a change from a 'hold' position, but it should be monitored in conjunction with other company news and financial performance.

Keywords

MaxLinear, MXL, Insider Sale, Form 4, Director, Stock Transaction, Daniel A. Artusi, 10b5-1 Plan